Abstract
Phosphofructokinase deficiency (Tarui disease, glycogen storage disease VII, GSD VII) stands out among all the GSDs. PFK deficiency was the first recognized disorder that directly affects glycolysis. Ever since the discovery of the disease in 1965, a wide range of biochemical, physiological and molecular studies of the disorder have greatly expanded our understanding of the function of normal muscle, general control of glycolysis and glycogen metabolism. The studies of PFK deficiency vastly enriched the field of glycogen storage diseases, as well as the field of metabolic and neuromuscular disorders. This article cites a historical overview of this clinical entity and the progress that has been made in molecular genetic area. We will also present the results of a search in-silico, which allowed us to identify a previously unknown sequence of the human platelet PFK gene (PFK-P). In addition, we will describe phylogenetic analysis of evolution of PFK genes.
Keywords: phosphofructokinase deficiency, tarui disease, glycogen storage disease Vll(gsd Vll)
Current Molecular Medicine
Title: Phosphofructokinase Deficiency Past, Present and Future
Volume: 2 Issue: 2
Author(s): Hiromu Nakajima, Nina Raben, Tomoya Hamaguchi and Tomoyuki Yamasaki
Affiliation:
Keywords: phosphofructokinase deficiency, tarui disease, glycogen storage disease Vll(gsd Vll)
Abstract: Phosphofructokinase deficiency (Tarui disease, glycogen storage disease VII, GSD VII) stands out among all the GSDs. PFK deficiency was the first recognized disorder that directly affects glycolysis. Ever since the discovery of the disease in 1965, a wide range of biochemical, physiological and molecular studies of the disorder have greatly expanded our understanding of the function of normal muscle, general control of glycolysis and glycogen metabolism. The studies of PFK deficiency vastly enriched the field of glycogen storage diseases, as well as the field of metabolic and neuromuscular disorders. This article cites a historical overview of this clinical entity and the progress that has been made in molecular genetic area. We will also present the results of a search in-silico, which allowed us to identify a previously unknown sequence of the human platelet PFK gene (PFK-P). In addition, we will describe phylogenetic analysis of evolution of PFK genes.
Export Options
About this article
Cite this article as:
Nakajima Hiromu, Raben Nina, Hamaguchi Tomoya and Yamasaki Tomoyuki, Phosphofructokinase Deficiency Past, Present and Future, Current Molecular Medicine 2002; 2 (2) . https://dx.doi.org/10.2174/1566524024605734
DOI https://dx.doi.org/10.2174/1566524024605734 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cardiac Innervation and Sudden Cardiac Death
Current Cardiology Reviews Arterial Stiffness:A Potential Therapeutic Target to Reduce Cardiovascular Mortality
Current Hypertension Reviews Review of Erectile Dysfunction in Diabetic Animal Models
Current Diabetes Reviews Toward Greater Insights on Applications of Modeling and Simulation in Pregnancy
Current Drug Metabolism Cross Currents in Protein Misfolding Disorders: Interactions and Therapy
CNS & Neurological Disorders - Drug Targets Inflammation Theories in Psychotic Disorders: A Critical Review
Infectious Disorders - Drug Targets Antifungal Agents in Hematopoietic Stem Cell Transplantation
Current Pharmaceutical Design Dynamical Properties of Steric Zipper Polymorphs Formed by a IAPPDerived Peptide
Protein & Peptide Letters Niacin: From Mechanisms of Action to Therapeutic Uses
Mini-Reviews in Medicinal Chemistry Glutathione Peroxidase: A Potential Marker for the Most Common Diseases and Disorders
Recent Patents on Biomarkers Obesity Pharmacotherapy: Current Perspectives and Future Directions
Current Cardiology Reviews Heat Shock Response Regulates Insulin Sensitivity and Glucose Homeostasis: Pathophysiological Impact and Therapeutic Potential
Current Diabetes Reviews Peripheral Arterial Disease: The Magnitude of the Problem and its Socioeconomic Impact
Current Drug Targets - Cardiovascular & Hematological Disorders Growth of Diabetes Research in United Arab Emirates: Current and Future Perspectives
Current Diabetes Reviews Analysis of QTc Interval during Levofloxacin Prescription in Cardiac Patients with Pneumonia
Current Drug Safety Metabolic Syndrome and Myocardial Infarction in Women
Current Pharmaceutical Design Phenolic Compounds: the Role of Redox Regulation in Neurodegenerative Disease and Cancer
Mini-Reviews in Medicinal Chemistry Gut Microbiota as a Therapeutic Target for Metabolic Disorders
Current Medicinal Chemistry Diabetes, Diabetic Complications, and Phosphate Toxicity: A Scoping Review
Current Diabetes Reviews Novel Treatments in Diabetic Nephropathy
Current Hypertension Reviews